Anti-Cathepsin D antibody
Specifications
| Product Cat#: | AB-06-0776 |
| Product type: | Primary antibody |
| Antigen: | Cathepsin D |
| Immunogen: | A synthetic peptide corresponding to residues near the N-terminus of human Cathepsin D |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot ( 1:1100 ); Immunohistochemistry ( 1:110-1:250 ); Immunocytochemistry ( 1:110 ) |
| Reactivity: | Human |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | Tris-HCl buffer (pH7.4), 1% BSA, 40% glycerol, 0.05% NaN3. |
| Concentration: | 1 mg/ml |
| Purity: | Tissue culture supernatant |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | CatD Antibody |
| CATD_HUMAN Antibody | |
| Cathepsin D Antibody | |
| Cathepsin D Heavy Chain Antibody | |
| CD Antibody | |
| Ceroid Lipofuscinosis Neuronal 10 Antibody | |
| CLN10 Antibody | |
| CPSD Antibody | |
| Ctsd Antibody | |
| Epididymis Secretory Sperm BindingProtein Li 130P Antibody | |
| HEL S 130P Antibody | |
| Lysosomal Aspartyl Peptidase Antibody | |
| Lysosomal Aspartyl Protease Antibody | |
| MGC2311 Antibody |
Show More
Target information
Acid protease active in intracellular protein breakdown. Plays a role in APP processing following cleavage and activation by ADAM30 which leads to APP degradation. Involved in the pathogenesis of several diseases such as breast cancer and possibly Alzheimer disease.
Provider
Erpantech Laboratory